Oxford Nanopore Technologies (ONT) Competitors GBX 166.51 -3.49 (-2.05%) As of 09/12/2025 12:56 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock ONT vs. BTG, ABC, GNS, OXB, ERGO, SLN, HZD, PRTC, VRP, and AVCTShould you be buying Oxford Nanopore Technologies stock or one of its competitors? The main competitors of Oxford Nanopore Technologies include BTG (BTG), Abcam (ABC), Genus (GNS), Oxford Biomedica (OXB), Ergomed (ERGO), Silence Therapeutics (SLN), Horizon Discovery Group plc (HZD.L) (HZD), PureTech Health (PRTC), Verona Pharma plc (VRP.L) (VRP), and Avacta Group (AVCT). These companies are all part of the "biotechnology" industry. Oxford Nanopore Technologies vs. Its Competitors BTG Abcam Genus Oxford Biomedica Ergomed Silence Therapeutics Horizon Discovery Group plc (HZD.L) PureTech Health Verona Pharma plc (VRP.L) Avacta Group Oxford Nanopore Technologies (LON:ONT) and BTG (LON:BTG) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, media sentiment, profitability and earnings. Do analysts recommend ONT or BTG? Oxford Nanopore Technologies currently has a consensus price target of GBX 245, indicating a potential upside of 47.14%. Given Oxford Nanopore Technologies' stronger consensus rating and higher probable upside, equities analysts plainly believe Oxford Nanopore Technologies is more favorable than BTG.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oxford Nanopore Technologies 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00BTG 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor ONT or BTG? In the previous week, BTG had 7 more articles in the media than Oxford Nanopore Technologies. MarketBeat recorded 13 mentions for BTG and 6 mentions for Oxford Nanopore Technologies. Oxford Nanopore Technologies' average media sentiment score of 1.06 beat BTG's score of 0.36 indicating that Oxford Nanopore Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oxford Nanopore Technologies 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BTG 2 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders hold more shares of ONT or BTG? 18.4% of Oxford Nanopore Technologies shares are held by institutional investors. 2.5% of Oxford Nanopore Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is ONT or BTG more profitable? BTG has a net margin of 0.00% compared to Oxford Nanopore Technologies' net margin of -94.82%. BTG's return on equity of 0.00% beat Oxford Nanopore Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Oxford Nanopore Technologies-94.82% -26.02% -14.42% BTG N/A N/A N/A Which has higher valuation & earnings, ONT or BTG? BTG has higher revenue and earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than BTG, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOxford Nanopore Technologies£204.69M7.84-£175.21M-£0.15-1,125.09BTG£914.10M0.00N/A£28.50N/A SummaryBTG beats Oxford Nanopore Technologies on 7 of the 13 factors compared between the two stocks. Get Oxford Nanopore Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ONT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ONT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONT vs. The Competition Export to ExcelMetricOxford Nanopore TechnologiesBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.60B£236.97M£5.87B£2.58BDividend YieldN/A3.78%5.68%5.30%P/E Ratio-1,125.0941.0874.525,410.94Price / Sales7.845,000.68516.4396,691.90Price / Cash4.0413.1937.5627.93Price / Book2.48103.7512.167.77Net Income-£175.21M-£90.99M£3.28B£5.89B7 Day Performance2.65%2.70%0.78%6.51%1 Month Performance-23.97%21.05%4.87%55.94%1 Year Performance14.05%530.95%60.72%147.85% Oxford Nanopore Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONTOxford Nanopore Technologies2.7809 of 5 starsGBX 166.51-2.1%GBX 245+47.1%+19.7%£1.60B£204.69M-1,125.091,281News CoveragePositive NewsAnalyst ForecastBTGBTGN/AN/AN/AN/A£3.26B£914.10M29.474,690ABCAbcamN/AN/AN/AN/A£2.81B£350.40M20,433.331,650Gap UpHigh Trading VolumeGNSGenus1.1229 of 5 starsGBX 2,695+0.9%GBX 2,725+1.1%+36.2%£1.77B£672.80M-43,467.74480High Trading VolumeOXBOxford Biomedica1.4883 of 5 starsGBX 595+0.8%GBX 540.25-9.2%+70.0%£715.08M£128.80M-1,425.15891High Trading VolumeERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumeHZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416PRTCPureTech Health1.7292 of 5 starsGBX 116.40-1.4%GBX 455+290.9%-22.3%£281.32M£6.17M684.71300News CoverageHigh Trading VolumeVRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpAVCTAvacta GroupN/AGBX 54.85-0.3%N/A-26.7%£220.37M£113K-357.56120 Related Companies and Tools Related Companies BTG Alternatives Abcam Alternatives Genus Alternatives Oxford Biomedica Alternatives Ergomed Alternatives Silence Therapeutics Alternatives Horizon Discovery Group plc (HZD.L) Alternatives PureTech Health Alternatives Verona Pharma plc (VRP.L) Alternatives Avacta Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:ONT) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Nanopore Technologies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Nanopore Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ONT Stock Alerts